Unlocking Success in Obesity Clinical Trials: Mastering Patient Engagement and Retention
Are you a biotech leader striving to revolutionize obesity treatment? Discover how mastering patient engagement and retention can be the game-changer for your clinical trials.
With groundbreaking advancements in obesity care, including next-gen GLP-1s, the key to clinical success lies not just in innovation but in maintaining robust patient engagement and retention throughout complex trials. Without sustained patient engagement, even the most promising therapies risk delays, data loss, or failure to demonstrate meaningful benefit. Obesity clinical trials face unique challenges, particularly in long-duration, placebo-controlled studies, where perceived benefit, stigma, and access challenges converge to increase dropout risk.
In this candid and solutions-focused webinar, you will hear from leaders who bring both clinical and personal experience to the conversation. From mental health and “food noise” to site operations and decentralized trial design, our panelists will share practical insights on how to improve the patient experience and retain participants throughout the trial journey. You will gain strategies to enhance retention, lessen site burden, and support patients throughout the trial.
Related Insights
Blog
Getting the small steps right for our biotech customers to make an exponential difference in patients’ lives
Jan 13, 2021
Podcast
Enabling Successful Sites, Episode 2: Empowering Sites to be More Inclusive Through Cultural Sensitivity Training
Jun 28, 2024
Blog
Decentralized Trials: Considerations for Building a New Patient-Centric Model
May 13, 2021
Webinar
Adaptive strategies for more efficient, data-rich and patient-friendly trials
May 28, 2023
Whitepaper
Execute with precision: Streamline operations for rapid and reliable enrollment
May 1, 2025
Blog
Patient Advocacy Groups: A vital partner for sponsors that understand how to engage with patients
May 3, 2022
Article
How emerging biotechs can enter the Chinese market and prosper
Jan 18, 2022
Podcast
Funding Biotech Innovation: How to Attract Investors
Jan 18, 2022
Blog
Three Ways Early-Stage Companies Can Attract Investors
Feb 3, 2022
Article
How biotechs can strengthen their value story with advanced analytics
Feb 15, 2022
Article
Getting to ‘No’ fast is more important when you are small
Mar 4, 2022
Blog
Toward more inclusive studies: Reaching and retaining patients from underrepresented communities
Apr 25, 2022
Related Insights
Blog
Getting the small steps right for our biotech customers to make an exponential difference in patients’ lives
Jan 13, 2021
Podcast
Enabling Successful Sites, Episode 2: Empowering Sites to be More Inclusive Through Cultural Sensitivity Training
Jun 28, 2024
Blog
Decentralized Trials: Considerations for Building a New Patient-Centric Model
May 13, 2021
Webinar
Adaptive strategies for more efficient, data-rich and patient-friendly trials
May 28, 2023
Whitepaper
Execute with precision: Streamline operations for rapid and reliable enrollment
May 1, 2025
Blog
Patient Advocacy Groups: A vital partner for sponsors that understand how to engage with patients
May 3, 2022
Article
How emerging biotechs can enter the Chinese market and prosper
Jan 18, 2022
Podcast
Funding Biotech Innovation: How to Attract Investors
Jan 18, 2022
Blog
Three Ways Early-Stage Companies Can Attract Investors
Feb 3, 2022
Article
How biotechs can strengthen their value story with advanced analytics
Feb 15, 2022
Article
Getting to ‘No’ fast is more important when you are small
Mar 4, 2022
Blog
Toward more inclusive studies: Reaching and retaining patients from underrepresented communities
Apr 25, 2022